| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00520-012-1445-4 |
| P698 | PubMed publication ID | 22476439 |
| P50 | author | Yin Ting Cheung | Q40223889 |
| Alexandre Chan | Q45839458 | ||
| P2093 | author name string | Earl Hsien-Jie Tan | |
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| Chemobrain: is systemic chemotherapy neurotoxic? | Q28251371 | ||
| The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology | Q29615701 | ||
| Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives | Q33194957 | ||
| The reliability and validity of qualitative scores for the Controlled Oral Word Association Test | Q33275075 | ||
| 'Chemobrain' in breast carcinoma?: a prologue | Q33980187 | ||
| Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy | Q34006211 | ||
| Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve | Q34334920 | ||
| The Functional Assessment of Cancer Therapy scale: development and validation of the general measure | Q34361336 | ||
| The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity | Q34482688 | ||
| The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial | Q34548140 | ||
| Mild cognitive impairment: conceptual issues and structural and functional brain correlates | Q35059777 | ||
| Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions | Q35060342 | ||
| Applications of computer-based neuropsychological assessment. | Q35152372 | ||
| Computerised neuropsychological testing | Q35325623 | ||
| A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. | Q35551034 | ||
| Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature | Q35635738 | ||
| Assessment practices of clinical neuropsychologists in the United States and Canada: a survey of INS, NAN, and APA Division 40 members | Q35994343 | ||
| Methodological problems in the neuropsychological assessment of effects of exposure to welding fumes and manganese | Q36058777 | ||
| Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer? | Q36789179 | ||
| Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy | Q36809058 | ||
| Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research | Q36814149 | ||
| Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study | Q36867082 | ||
| Cognitive function after chemotherapy in adults with solid tumours | Q36902099 | ||
| Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. | Q37121868 | ||
| Cognitive functioning in breast cancer survivors: a controlled comparison | Q37157773 | ||
| Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors | Q37382652 | ||
| Subjective cognitive dysfunction in breast cancer patients: a systematic review | Q37658591 | ||
| Neuro-cognitive impairment in breast cancer patients: pharmacological considerations | Q37947927 | ||
| The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study | Q39931915 | ||
| Cognitive impairments associated with breast cancer treatments: results from a longitudinal study | Q40070425 | ||
| Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer | Q40306862 | ||
| CANTAB battery: proposed utility in neurotoxicology. | Q41159974 | ||
| Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men. | Q41167179 | ||
| Psychometric issues associated with computerised neuropsychological assessment of concussed athletes. | Q41851081 | ||
| Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study | Q42162266 | ||
| Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer | Q43011861 | ||
| Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study | Q43122484 | ||
| Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma | Q43131985 | ||
| Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function | Q43626067 | ||
| The effects of anticancer chemotherapeutic drugs on cognitive function and other neuropsychiatric dimensions in breast cancer patients | Q43911197 | ||
| Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients | Q44114761 | ||
| Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer | Q45177690 | ||
| Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen | Q45293570 | ||
| Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment | Q45481799 | ||
| Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide | Q46572731 | ||
| Cognitive impairment associated with adjuvant therapy in breast cancer | Q46647395 | ||
| A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function | Q46784141 | ||
| Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight | Q46847555 | ||
| Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments | Q46856597 | ||
| Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer | Q47607375 | ||
| Development and validation of a web-based screening tool for monitoring cognitive status | Q47840847 | ||
| CogSport: reliability and correlation with conventional cognitive tests used in postconcussion medical evaluations | Q48402516 | ||
| Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy | Q48588289 | ||
| Test-retest reliability of three aphasia tests: performance of non-brain-damaged older adults | Q48813502 | ||
| One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer | Q49019819 | ||
| A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients | Q49052219 | ||
| Test-retest stability and practice effects of the RBANS in a community dwelling elderly sample | Q50128402 | ||
| Effect of repeated administration of a neuropsychological battery in the elderly | Q50545997 | ||
| Repeated testing of normal elderly with the Boston Naming Test. | Q50594375 | ||
| Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. | Q50963195 | ||
| A prospective study of cognitive complaints in patients with testicular cancer. | Q51001223 | ||
| Cognitive function in breast cancer patients receiving adjuvant chemotherapy. | Q51079423 | ||
| Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. | Q51099382 | ||
| Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. | Q51668725 | ||
| The Attentional Function Index--a self-report cognitive measure. | Q51854484 | ||
| Predictors of cognitive decline after chemotherapy in breast cancer patients. | Q51890841 | ||
| Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: daily self-report and objective behavior. | Q51952589 | ||
| Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. | Q51984807 | ||
| Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. | Q51986288 | ||
| Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals. | Q52012550 | ||
| Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. | Q52028216 | ||
| Development and validation of a Multiple Ability Self-Report Questionnaire. | Q52058998 | ||
| The development and initial validation of a sensitive bedside cognitive screening test. | Q52067618 | ||
| The reaction of psychiatric patients to computerized assessment. | Q52073227 | ||
| Validity of the construct of nonverbal memory: a factor-analytic study in a normal elderly sample | Q52077584 | ||
| The Cognitive Failures Questionnaire (CFQ) and its correlates. | Q52099280 | ||
| International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. | Q53158179 | ||
| Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. | Q53226410 | ||
| Assessing cognitive function in cancer patients. | Q53253459 | ||
| Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer | Q53365999 | ||
| Psychological test usage: Implications in professional psychology | Q55896063 | ||
| No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy | Q57391252 | ||
| The (mis)classification of chemo-fog – methodological inconsistencies in the investigation of cognitive impairment after chemotherapy | Q57922231 | ||
| Cognitive functions and elderly cancer patients receiving anticancer treatment: A prospective study | Q60637129 | ||
| A comparison of computerized and standard versions of the Wisconsin Card Sorting Test | Q73569221 | ||
| Comparison of seven-subtest and Satz-Mogel short forms of the WAIS-III | Q74697044 | ||
| Development and preliminary validation of a Satz-Mogel short form of the WAIS-III in a sample of persons with substance abuse disorders | Q77966338 | ||
| The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy | Q79826254 | ||
| Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects | Q81631400 | ||
| Conners' Continuous Performance Test (2nd ed.; CCPT-II) | Q82566834 | ||
| P433 | issue | 7 | |
| P921 | main subject | neuropsychology | Q3872 |
| P304 | page(s) | 1361-1375 | |
| P577 | publication date | 2012-04-05 | |
| P1433 | published in | Supportive Care in Cancer | Q15766919 |
| P1476 | title | An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors | |
| P478 | volume | 20 |
| Q36543428 | Associations Between Physical Fitness Indices and Working Memory in Breast Cancer Survivors and Age-Matched Controls |
| Q44287983 | Brief self-report measure of work-related cognitive limitations in breast cancer survivors |
| Q38088668 | Clearing the air: a review of our current understanding of "chemo fog". |
| Q30945359 | Cognitive complaints in cancer: The French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), normative data from a healthy population |
| Q37067793 | Cognitive function in cancer survivors: analysis of the 1999-2002 National Health and Nutrition Examination Survey |
| Q48334506 | Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients. |
| Q60685909 | Linguistic validation of Functional Assessment of Cancer Therapy–Cognitive Function (FACT-Cog): methodological concerns |
| Q88723610 | Neuropsychological profiles of breast cancer and brain tumor cohorts in Northeast Ontario, Canada |
| Q92501092 | Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy |
| Q39814546 | Prospective memory impairment in chemotherapy-exposed early breast cancer survivors: Preliminary evidence from a clinical test |
| Q39016218 | Return to work among breast cancer survivors: A literature review. |
| Q44165418 | Women's experiences of cognitive changes or 'chemobrain' following treatment for breast cancer: a role for occupational therapy? |
Search more.